| NCT04323202 |
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N |
https://ClinicalTrials.gov/show/NCT04323202 |
Recruiting |
Case Comprehensive Cancer Center |
2021-06-15 |
| NCT03237013 |
Strategies to Promote Skin Health |
https://ClinicalTrials.gov/show/NCT03237013 |
Completed |
San Diego State University |
2016-12-14 |
| NCT03180528 |
Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer |
https://ClinicalTrials.gov/show/NCT03180528 |
Active, not recruiting |
Stanford University |
2020-06-28 |
| NCT03167762 |
Photographing the Skin During Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT03167762 |
Enrolling by invitation |
University of Dundee |
2020-06-01 |
| NCT03132636 |
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy |
https://ClinicalTrials.gov/show/NCT03132636 |
Active, not recruiting |
Regeneron Pharmaceuticals |
2021-10-14 |
| NCT03035188 |
Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03035188 |
Active, not recruiting |
SRH Wald-Klinikum Gera GmbH |
2019-12-31 |
| NCT03012009 |
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT03012009 |
Completed |
University Hospital, Ghent |
2017-05-31 |
| NCT02978625 |
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers |
https://ClinicalTrials.gov/show/NCT02978625 |
Recruiting |
National Cancer Institute (NCI) |
2021-06-01 |
| NCT02939027 |
Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02939027 |
Completed |
Instituto de Investigacion Sanitaria La Fe |
2016-07-31 |
| NCT02902822 |
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo |
https://ClinicalTrials.gov/show/NCT02902822 |
Completed |
Centro Studi Gised |
2019-05-31 |
| NCT02828111 |
Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT02828111 |
Completed |
PellePharm, Inc. |
2017-11-09 |
| NCT02762084 |
Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients |
https://ClinicalTrials.gov/show/NCT02762084 |
Completed |
PellePharm, Inc. |
2017-04-24 |
| NCT02735356 |
Topical Itraconazole in Treating Patients With Basal Cell Cancer |
https://ClinicalTrials.gov/show/NCT02735356 |
Completed |
Stanford University |
2017-09-19 |
| NCT02690948 |
Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer |
https://ClinicalTrials.gov/show/NCT02690948 |
Completed |
Stanford University |
2017-11-30 |
| NCT02668614 |
Early Detection of Skin Cancer With Sensor Technology |
https://ClinicalTrials.gov/show/NCT02668614 |
Completed |
Lawson Health Research Institute |
2018-02-28 |
| NCT02667574 |
Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT02667574 |
Active, not recruiting |
University Hospital, Lille |
2019-12-31 |
| NCT02662244 |
Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02662244 |
Completed |
University of California, San Diego |
2016-09-30 |
| NCT02639117 |
Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT02639117 |
Completed |
University of Arizona |
2016-11-02 |
| NCT02623101 |
Reflectance Confocal Microscopy in Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02623101 |
Completed |
Radboud University |
2019-05-31 |
| NCT02587819 |
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment |
https://ClinicalTrials.gov/show/NCT02587819 |
Completed |
Biosceptre |
2013-10-31 |
| NCT02580916 |
Utility of the Skin Cancer Quality of Life Impact Tool |
https://ClinicalTrials.gov/show/NCT02580916 |
Completed |
Oxford University Hospitals NHS Trust |
2017-08-31 |
| NCT02550678 |
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02550678 |
Completed |
Ascend Biopharmaceuticals Ltd |
2017-11-30 |
| NCT02436408 |
VISmodegib for ORbital and Periocular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02436408 |
Active, not recruiting |
University of Michigan Rogel Cancer Center |
2021-03-31 |
| NCT02409628 |
EktoTherixâ„¢ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds |
https://ClinicalTrials.gov/show/NCT02409628 |
Completed |
Neotherix Limited |
2017-07-31 |
| NCT02367547 |
Superficial Basal Cell Cancer’s Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL |
https://ClinicalTrials.gov/show/NCT02367547 |
Active, not recruiting |
Joint Authority for Päijät-Häme Social and Health Care |
2018-09-30 |
| NCT02354261 |
Open-label Trial of SUBAâ„¢-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) |
https://ClinicalTrials.gov/show/NCT02354261 |
Active, not recruiting |
HedgePath Pharmaceuticals, Inc. |
2019-03-31 |
| NCT02352428 |
Skin Cancer Screening Education Study |
https://ClinicalTrials.gov/show/NCT02352428 |
Active, not recruiting |
Association of Dermatological Prevention, Germany |
2018-12-31 |
| NCT02285790 |
One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy |
https://ClinicalTrials.gov/show/NCT02285790 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2015-10-31 |
| NCT02270645 |
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser |
https://ClinicalTrials.gov/show/NCT02270645 |
Completed |
University of Miami |
2017-06-30 |
| NCT02242929 |
Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02242929 |
Active, not recruiting |
Maastricht University Medical Center |
2017-12-31 |
| NCT02144077 |
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT02144077 |
Active, not recruiting |
Biofrontera Bioscience GmbH |
2015-11-30 |
| NCT02125669 |
Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT02125669 |
Completed |
Hautklinik Darmstadt |
2013-09-30 |
| NCT02123511 |
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02123511 |
Completed |
Mayo Clinic |
2016-03-22 |
| NCT02120677 |
Topical Itraconazole in the Treatment of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02120677 |
Completed |
Johns Hopkins University |
2019-01-30 |
| NCT01298167 |
Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery |
https://ClinicalTrials.gov/show/NCT01298167 |
Completed |
Yale University |
2011-08-31 |
| NCT01292668 |
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer |
https://ClinicalTrials.gov/show/NCT01292668 |
Completed |
Roswell Park Cancer Institute |
2012-07-31 |
| NCT02029352 |
Topical Green Tea Ointment in Treatment of Superficial Skin Cancer |
https://ClinicalTrials.gov/show/NCT02029352 |
Completed |
Maastricht University Medical Center |
2015-09-30 |
| NCT03897036 |
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT03897036 |
Recruiting |
Senhwa Biosciences, Inc. |
2020-07-31 |
| NCT02018679 |
Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02018679 |
Completed |
Dong-A University |
2013-02-28 |
| NCT02017964 |
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02017964 |
Active, not recruiting |
Children’s Oncology Group |
2018-03-31 |
| NCT02007317 |
Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study |
https://ClinicalTrials.gov/show/NCT02007317 |
Completed |
Oshadi Drug Administration |
2017-03-31 |
| NCT01980264 |
Harmonics-based in Vivo Optical Virtual Biopsy |
https://ClinicalTrials.gov/show/NCT01980264 |
Recruiting |
National Taiwan University Hospital |
2020-12-31 |
| NCT01835626 |
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01835626 |
Completed |
University of California, San Francisco |
2019-09-10 |
| NCT01815840 |
A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT01815840 |
Completed |
Hoffmann-La Roche |
2015-08-27 |
| NCT01806675 |
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy |
https://ClinicalTrials.gov/show/NCT01806675 |
Completed |
Stanford University |
2016-12-07 |
| NCT01791894 |
Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01791894 |
Completed |
Stanford University |
2013-11-30 |
| NCT01773447 |
Set-back Suture Versus Traditional Vertical Mattress Suture |
https://ClinicalTrials.gov/show/NCT01773447 |
Completed |
University of California, Davis |
2014-03-31 |
| NCT01700049 |
Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes |
https://ClinicalTrials.gov/show/NCT01700049 |
Completed |
Mayo Clinic |
2017-07-03 |
| NCT01637194 |
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01637194 |
Completed |
Fox Chase Cancer Center |
2011-07-31 |
| NCT01631331 |
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT01631331 |
Completed |
Stanford University |
2015-09-17 |
| NCT01609179 |
IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 |
https://ClinicalTrials.gov/show/NCT01609179 |
Completed |
Infinity Pharmaceuticals, Inc. |
2012-10-31 |
| NCT01556009 |
Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT01556009 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2015-12-31 |
| NCT01543581 |
Vismodegib for Treatment of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01543581 |
Completed |
Loma Linda University |
2013-06-30 |
| NCT01529450 |
Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors |
https://ClinicalTrials.gov/show/NCT01529450 |
Completed |
Stanford University |
2013-08-31 |
| NCT01482104 |
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT01482104 |
Completed |
Norwegian University of Science and Technology |
2017-10-31 |
| NCT01463709 |
Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer |
https://ClinicalTrials.gov/show/NCT01463709 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2012-06-30 |
| NCT01455363 |
Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01455363 |
Completed |
Institut Curie |
2011-10-31 |
| NCT01367665 |
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01367665 |
Completed |
Hoffmann-La Roche |
2017-06-14 |
| NCT01358045 |
Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01358045 |
Completed |
Maastricht University Medical Center |
2013-02-28 |
| NCT01350115 |
Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) |
https://ClinicalTrials.gov/show/NCT01350115 |
Completed |
Novartis |
2012-10-31 |
| NCT01327053 |
A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01327053 |
Completed |
Novartis |
2013-06-28 |
| NCT01325688 |
PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities |
https://ClinicalTrials.gov/show/NCT01325688 |
Completed |
Peplin |
2012-03-31 |
| NCT04389112 |
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions |
https://ClinicalTrials.gov/show/NCT04389112 |
Recruiting |
University Hospital, Bordeaux |
2021-02-28 |
| NCT04279535 |
Topical Vitamin C for Treatment of Basal Cell Cancer |
https://ClinicalTrials.gov/show/NCT04279535 |
Completed |
Center for Biomedical Research, Inc. |
2019-03-01 |
| NCT04155190 |
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC |
https://ClinicalTrials.gov/show/NCT04155190 |
Recruiting |
PellePharm, Inc. |
2020-06-30 |
| NCT04124796 |
Identification of Psychosocial Factors Associated With Diagnostic Delay in Advanced Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04124796 |
Completed |
University Hospital, Bordeaux |
2019-11-12 |
| NCT04093401 |
The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated. |
https://ClinicalTrials.gov/show/NCT04093401 |
Recruiting |
University of Wisconsin, Madison |
2020-10-31 |
| NCT03972748 |
Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin. |
https://ClinicalTrials.gov/show/NCT03972748 |
Recruiting |
Hospital de Clinicas de Porto Alegre |
2020-12-01 |
| NCT03848078 |
(Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT03848078 |
Recruiting |
Maastricht University Medical Center |
2021-02-26 |
| NCT03816332 |
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers |
https://ClinicalTrials.gov/show/NCT03816332 |
Recruiting |
National Cancer Institute (NCI) |
2021-05-30 |
| NCT03775525 |
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT03775525 |
Recruiting |
Genzada Pharmaceuticals USA, Inc. |
2020-09-30 |
| NCT03769285 |
Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial |
https://ClinicalTrials.gov/show/NCT03769285 |
Recruiting |
Women’s College Hospital |
2020-12-31 |
| NCT03742726 |
Study Assessing the Safety and Performance of Smart Matrix® |
https://ClinicalTrials.gov/show/NCT03742726 |
Recruiting |
Smart Matrix Limited |
2021-02-28 |
| NCT03714529 |
A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03714529 |
Recruiting |
Herlev and Gentofte Hospital |
2019-01-15 |
| NCT03703310 |
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) |
https://ClinicalTrials.gov/show/NCT03703310 |
Active, not recruiting |
PellePharm, Inc. |
2020-12-06 |
| NCT03646188 |
Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity and Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in BCC |
https://ClinicalTrials.gov/show/NCT03646188 |
Recruiting |
SkinJect, Inc. |
2020-12-01 |
| NCT03610620 |
Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery |
https://ClinicalTrials.gov/show/NCT03610620 |
Completed |
Norfolk and Norwich University Hospitals NHS Foundation Trust |
2018-08-09 |
| NCT03610022 |
Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 |
https://ClinicalTrials.gov/show/NCT03610022 |
Recruiting |
University Hospital, Bordeaux |
2020-11-30 |
| NCT03573401 |
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). |
https://ClinicalTrials.gov/show/NCT03573401 |
Recruiting |
Biofrontera Bioscience GmbH |
2021-07-31 |
| NCT03569345 |
Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate |
https://ClinicalTrials.gov/show/NCT03569345 |
Completed |
Bispebjerg Hospital |
2018-05-18 |
| NCT03541252 |
Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma― a Clinical Study |
https://ClinicalTrials.gov/show/NCT03541252 |
Recruiting |
Bispebjerg Hospital |
2019-01-31 |
| NCT03534947 |
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03534947 |
Recruiting |
Melanoma Institute Australia |
2020-12-31 |
| NCT03521830 |
Nivolumab Alone or Plus Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03521830 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2023-11-30 |
| NCT03517488 |
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03517488 |
Recruiting |
Xencor, Inc. |
2020-12-31 |
| NCT03509467 |
Using MC1R Genotype to Impact Melanoma Risk Behavior |
https://ClinicalTrials.gov/show/NCT03509467 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-11-30 |
| NCT03483441 |
Vitamin D and Photodynamic Therapy for Treatment of BCC in BCNS |
https://ClinicalTrials.gov/show/NCT03483441 |
Recruiting |
The Cleveland Clinic |
2022-05-01 |
| NCT03467789 |
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03467789 |
Recruiting |
Case Comprehensive Cancer Center |
2021-11-30 |
| NCT03458117 |
T-VEC in Non-melanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT03458117 |
Recruiting |
University of Zurich |
2020-02-29 |
| NCT01770002 |
Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? |
https://ClinicalTrials.gov/show/NCT01770002 |
Completed |
University of California, Davis |
2013-09-30 |
| NCT01260987 |
Fractional CO2 Laser Assisted Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT01260987 |
Completed |
Bispebjerg Hospital |
2012-08-31 |
| NCT01245972 |
Pilot Study of PDL to Treat BCC and SCCIS |
https://ClinicalTrials.gov/show/NCT01245972 |
Completed |
University of California, San Diego |
2011-06-30 |
| NCT01212549 |
Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01212549 |
Completed |
University of Ioannina |
2010-01-31 |
| NCT01208831 |
An East Asian Study of LDE225 |
https://ClinicalTrials.gov/show/NCT01208831 |
Completed |
Novartis |
2013-10-31 |
| NCT01204073 |
A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01204073 |
Completed |
Millennium Pharmaceuticals, Inc. |
2012-12-31 |
| NCT01201915 |
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01201915 |
Completed |
Genentech, Inc. |
2013-05-31 |
| NCT01155609 |
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01155609 |
Completed |
University of Washington |
2011-12-31 |
| NCT01108094 |
Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT01108094 |
Completed |
Stanford University |
2011-03-31 |
| NCT01106508 |
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01106508 |
Completed |
Novartis |
2015-06-30 |
| NCT01015898 |
Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01015898 |
Completed |
Shahid Beheshti University of Medical Sciences |
2008-07-31 |
| NCT00988455 |
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up |
https://ClinicalTrials.gov/show/NCT00988455 |
Completed |
Shahid Beheshti University of Medical Sciences |
2009-03-31 |
| NCT00985829 |
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00985829 |
Completed |
Shahid Beheshti University of Medical Sciences |
2008-07-31 |
| NCT00961896 |
A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients |
https://ClinicalTrials.gov/show/NCT00961896 |
Completed |
Novartis |
2010-08-31 |
| NCT00959647 |
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study |
https://ClinicalTrials.gov/show/NCT00959647 |
Completed |
Genentech, Inc. |
2014-01-31 |
| NCT00880308 |
Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00880308 |
Completed |
Novartis |
2013-07-31 |
| NCT00847912 |
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial |
https://ClinicalTrials.gov/show/NCT00847912 |
Completed |
VA Office of Research and Development |
2013-06-28 |
| NCT03982212 |
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors |
https://ClinicalTrials.gov/show/NCT03982212 |
Recruiting |
University of Kansas Medical Center |
2020-07-31 |
| NCT00833417 |
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00833417 |
Completed |
Genentech, Inc. |
2010-11-30 |
| NCT03734913 |
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03734913 |
Recruiting |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
2020-11-01 |
| NCT02579551 |
Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT02579551 |
Completed |
Thomas Jefferson University |
2014-02-01 |
| NCT02834013 |
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
https://ClinicalTrials.gov/show/NCT02834013 |
Recruiting |
National Cancer Institute (NCI) |
2021-08-31 |
| NCT02158650 |
Video-Based Treatment Options for Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02158650 |
Completed |
Emory University |
2015-08-31 |
| NCT04229277 |
Fast Track Diagnosis of Skin Cancer by Advanced Imaging |
https://ClinicalTrials.gov/show/NCT04229277 |
Active, not recruiting |
University Hospital Bispebjerg and Frederiksberg |
2020-03-22 |
| NCT00765193 |
The Impact of Total Body Skin Examination on Skin Cancer Detection |
https://ClinicalTrials.gov/show/NCT00765193 |
Completed |
Medical University of Graz |
2009-05-31 |
| NCT00670189 |
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00670189 |
Completed |
Bristol-Myers Squibb |
2014-04-30 |
| NCT00604890 |
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00604890 |
Completed |
Berg, LLC |
2010-01-31 |
| NCT00586040 |
Photochemical Tissue Bonding |
https://ClinicalTrials.gov/show/NCT00586040 |
Completed |
Massachusetts General Hospital |
2009-04-30 |
| NCT00581425 |
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) |
https://ClinicalTrials.gov/show/NCT00581425 |
Completed |
The University of Texas Health Science Center, Houston |
2011-09-30 |
| NCT00578214 |
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery |
https://ClinicalTrials.gov/show/NCT00578214 |
Completed |
Mayo Clinic |
2008-04-30 |
| NCT00571363 |
A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs’ Surgery of Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00571363 |
Completed |
NHS Tayside |
NA |
| NCT00492089 |
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00492089 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT00473343 |
Metvix PDT in Patients With “High Risk” Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00473343 |
Completed |
Galderma |
NA |
| NCT00472459 |
PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT00472459 |
Completed |
Galderma |
NA |
| NCT00472108 |
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00472108 |
Completed |
Galderma |
NA |
| NCT00472043 |
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma |
https://ClinicalTrials.gov/show/NCT00472043 |
Completed |
Galderma |
NA |
| NCT00470496 |
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00470496 |
Completed |
Roswell Park Cancer Institute |
2011-10-28 |
| NCT00469417 |
Metvix PDT Versus Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00469417 |
Completed |
Galderma |
NA |
| NCT00432185 |
To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC |
https://ClinicalTrials.gov/show/NCT00432185 |
Completed |
Peplin |
2010-03-31 |
| NCT00374062 |
Effect of the Subconscious on Mohs Micrographic Surgery |
https://ClinicalTrials.gov/show/NCT00374062 |
Completed |
Northwestern University |
2009-08-31 |
| NCT00314756 |
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage |
https://ClinicalTrials.gov/show/NCT00314756 |
Completed |
Wake Forest University Health Sciences |
NA |
| NCT00237107 |
Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment. |
https://ClinicalTrials.gov/show/NCT00237107 |
Completed |
Norwegian University of Science and Technology |
2004-12-31 |
| NCT00204555 |
Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00204555 |
Completed |
University Hospital Tuebingen |
NA |
| NCT00189306 |
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream |
https://ClinicalTrials.gov/show/NCT00189306 |
Completed |
Graceway Pharmaceuticals, LLC |
2007-04-30 |
| NCT00189280 |
Aldara for the Treatment of Large and/or Multiple sBCC |
https://ClinicalTrials.gov/show/NCT00189280 |
Completed |
MEDA Pharma GmbH & Co. KG |
2007-10-31 |
| NCT00189241 |
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00189241 |
Completed |
MEDA Pharma GmbH & Co. KG |
2007-02-28 |
| NCT00188370 |
Ultrasound Biomicroscopy - Apoptosis |
https://ClinicalTrials.gov/show/NCT00188370 |
Completed |
University Health Network, Toronto |
NA |
| NCT00129519 |
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence |
https://ClinicalTrials.gov/show/NCT00129519 |
Completed |
Graceway Pharmaceuticals, LLC |
2006-01-31 |
| NCT00108134 |
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00108134 |
Completed |
Peplin |
2006-03-31 |
| NCT00108121 |
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00108121 |
Completed |
Peplin |
2006-05-31 |
| NCT00101348 |
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00101348 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00089362 |
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors |
https://ClinicalTrials.gov/show/NCT00089362 |
Completed |
National Cancer Institute (NCI) |
2008-01-31 |
| NCT00089180 |
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant |
https://ClinicalTrials.gov/show/NCT00089180 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00068497 |
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00068497 |
Completed |
National Cancer Institute (NCI) |
2007-12-31 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00030498 |
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
https://ClinicalTrials.gov/show/NCT00030498 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00023959 |
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00023959 |
Completed |
National Cancer Institute (NCI) |
2010-03-31 |
| NCT00007631 |
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT00007631 |
Completed |
VA Office of Research and Development |
2004-11-30 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |